Multi-stent and multi-balloon apparatus for treating bifurcations and methods of use

Information

  • Patent Grant
  • 11484424
  • Patent Number
    11,484,424
  • Date Filed
    Wednesday, July 31, 2019
    5 years ago
  • Date Issued
    Tuesday, November 1, 2022
    2 years ago
Abstract
A system for treating a bifurcated vessel that includes a first delivery catheter and a second delivery catheter. The first delivery catheter carries a proximal first stent and a distal second stent. The first delivery catheter also has a first elongate shaft, a proximal first expandable member with the proximal first stent disposed thereover, and a distal second expandable member with the distal second stent disposed thereover. The proximal first expandable member and distal second expandable member are independently expandable of one another. The second delivery catheter carries a third stent. The second delivery catheter also has a second elongate shaft, and a third expandable member with the third stent disposed thereover. The third expandable member is independently expandable of the proximal first expandable member and the distal second expandable member.
Description
BACKGROUND OF THE INVENTION

Angioplasty and stenting of blood vessels or other body lumens are commonly performed today. Angioplasty is often performed by expanding a balloon in a vessel in order to reduce or eliminate plaque or other blockages. In many cases, a stent is also implanted in the vessel in order to further ensure a positive clinical result. A stent is an implantable scaffold that is typically delivered percutaneously and deployed in a vein, artery, or other tubular body organ for treating an occlusion, stenosis, aneurysm, collapse, dissection, or weakened, diseased, or abnormally dilated vessel or vessel wall. The stent is radially expanded in situ, thereby expanding and/or supporting the vessel wall or body organ wall. In particular, stents are quite commonly implanted in the coronary, cardiac, pulmonary, neurovascular, peripheral vascular, renal, gastrointestinal and reproductive systems. Stents have also been successfully used to reinforce other body parts, such as the urinary tract, the bile duct, the esophagus, the tracheo-bronchial tree and the brain.


Stents may improve angioplasty results by preventing elastic recoil and remodeling of the vessel wall. Stents also can be used to treat dissections in blood vessel walls that are caused by balloon angioplasty. In this situation, the stent is used to appose dissected intimal flaps of tissue which otherwise would extend into and block a vessel.


Conventional stents have also been used to treat more complex vascular problems, such as lesions at or near bifurcation points in the vascular system. A bifurcation is where a secondary artery (sometimes referred to as a side branch or daughter vessel) branches out of a typically larger vessel (sometimes referred to as the main branch or mother vessel). Stenting of bifurcations can present may challenges. For example, a stent that traverses the ostium of the side branch may obstruct blood flow into the side branch. Moreover, the struts in a stent may also block the side branch, limiting or preventing access to the side branch by another diagnostic or therapeutic device such as another catheter. This phenomenon is commonly referred to as “stent jailing.” In still other situations, inflation of balloons and expansion of stents in a bifurcation can result in undesirable plaque shifting, which is sometimes referred to as “snow plowing.” Other challenges with treatment of a bifurcated vessel can be the result of vessel spasm, dissection, thrombosis, etc.


More recently stents and balloons have also been used to elute drugs locally to the treatment site. Drugs such as rapamycin, everolimus, biolimus A9 and other analogs of rapamycin, as well as paclitaxel are promising in reducing restenosis rates, yet many of the aforementioned challenges of treating a bifurcation still exist.


It would therefore be desirable to provide improved medical devices and methods for treating bifurcated vessels. It would also be desirable to provide improved medical devices and methods that are easier to use, safer, more reliable, and that provide a better clinical outcome compared with currently available medical devices.


Therefore, given the challenges of current stent technology, a need exists for improved stent delivery systems and methods, particularly for treating bifurcated vessels. At least some of these objectives will be met by the present invention.


BRIEF SUMMARY OF THE INVENTION

The present invention relates to methods and delivery systems used to dilate and/or deliver stents in a bifurcated vessel. Embodiments may be configured to stent at least a portion of a mother vessel and a portion of a daughter vessel.


In a first aspect of the present invention, a system for treating a patient's bifurcated vessel having a main branch and a side branch comprises a first delivery catheter and a second delivery catheter. The first delivery catheter carries a first stent which comprises a proximal stent and a distal stent. The first delivery catheter also has a first elongate shaft with a proximal and a distal end. A proximal expandable member has the proximal stent disposed thereover, and a distal expandable member has the distal stent disposed thereover. The proximal and distal expandable members are disposed adjacent the distal end of the first elongate shaft. The proximal and distal expandable members each have a collapsed configuration and a radially expanded configuration. The collapsed configuration has a profile suitable for advancement through a blood vessel, and the expanded configuration has a larger profile than the collapsed configuration profile. The proximal and the distal expandable members are independently expandable of one another.


The second delivery catheter carries a second stent, and also has a second elongate shaft with a proximal and a distal end. A second expandable member with the second stent disposed thereover is disposed adjacent the distal end of the second elongate shaft. The second expandable member has a collapsed configuration and a radially expanded configuration. The collapsed configuration has a profile suitable for advancement through a blood vessel, and the expanded configuration has a larger profile than the profile in the collapsed configuration. The second expandable member is independently expandable of the proximal and the distal expandable members.


In another aspect of the present invention, a system for dilating a bifurcated vessel having a main branch and a side branch in a patient comprises a first delivery catheter and a second delivery catheter. The first delivery catheter has a first elongate shaft with a proximal and a distal end, a proximal expandable member, and a distal expandable member. The proximal and distal expandable members are disposed adjacent the distal end of the first elongate shaft. The proximal and distal expandable members each have a collapsed configuration and a radially expanded configuration. The collapsed configuration has a profile suitable for advancement through a blood vessel, and the expanded configuration has a larger profile than the collapsed configuration profile. The proximal and distal expandable members are independently expandable of one another.


The second delivery catheter has a second elongate shaft with a proximal and a distal end, and a second expandable member. The second expandable member is disposed adjacent the distal end of the second elongate shaft. The second expandable member has a collapsed configuration and a radially expanded configuration. The collapsed configuration has a profile suitable for advancement through a blood vessel, and the expanded configuration has a larger profile than the profile in the collapsed configuration. The second expandable member is independently expandable of the proximal and the distal expandable members.


The first delivery catheter may be adapted to deliver the proximal and distal stents to the main branch adjacent the bifurcation. The second delivery catheter may be adapted to deliver the second stent to the side branch adjacent the bifurcation. A portion of the second delivery catheter may be disposed under a portion of the proximal stent or under a portion of the distal stent, or under a portion of both. The second delivery catheter may be axially slidable relative to the first delivery catheter. The first elongate shaft may comprise a lumen which extends at least partially between proximal and distal ends of the first elongate shaft, and the lumen may be sized to slidably receive the second elongate shaft. The second delivery catheter may be fixed relative to the first delivery catheter so that relative axial movement between the two delivery catheters is prohibited.


Each of the stents may have a collapsed configuration suitable for delivery to the bifurcation, and a radially expanded configuration adapted to engage and support a vessel wall at the bifurcation or adjacent the bifurcation. Each of the stents may be crimped to its respective expandable member so as to prevent ejection of the stent during advancement through a patient's vasculature. A proximal end of the distal stent in the collapsed configuration may abut a distal end of the proximal stent in the collapsed configuration. A proximal end of the distal stent may abut a distal end of the proximal stent so as to form a sidehole in the first stent. The proximal end of the distal stent may comprise a notched region, and the distal end of the proximal stent may also comprise a notched region. The second delivery catheter may slidably pass through the side hole in the first stent. A proximal end of the second stent may comprise a beveled section adapted to fit flush against a sidewall of the proximal stent or a sidewall of the distal stent. A proximal end of the second stent in the radially expanded configuration may be aligned with and abut a side of both the proximal stent in the radially expanded configuration and a side of the distal stent in the radially expanded configuration.


A gap may separate the proximal and the distal expandable members when both the proximal and the distal expandable members are in the collapsed configuration. The gap may be disposed between a proximal end of distal expandable member and a distal end of the proximal expandable member. Expansion of the proximal and the distal members may displace the proximal end of the distal expandable member relative to the distal end of the proximal expandable member so that the proximal end of the distal expandable member advances toward the distal end of the proximal expandable member. This may decrease the gap between the proximal and the distal expandable members. The proximal end of the distal expandable member may abut the distal end of the proximal expandable member when both the proximal and the distal expandable members are in the expanded configuration. The proximal expandable member, the distal expandable member, or the second expandable member may comprise a balloon. A proximal end of the second expandable member may abut a side of both the proximal and the distal expandable members when the proximal, the distal, and the second expandable members are in the radially expanded configuration.


At least one of the first elongate shaft or the second elongate shaft may comprise a guidewire lumen extending at least partially between its proximal and distal ends. The guidewire lumen may be sized to slidably receive a guidewire. The first elongate shaft may comprise a proximal guidewire port and a distal guidewire port adjacent the distal end thereof, and the proximal guidewire port may be closer to the proximal end of the first elongate shaft than the distal end of the first elongate shaft. The proximal guidewire port may be closer to the distal guidewire port than the proximal end of the first elongate shaft. The second elongate shaft may comprise a proximal guidewire port and a distal guidewire port adjacent the distal end thereof, and the proximal guidewire port may be closer to the proximal end of the second elongate shaft than the distal end of the second elongate shaft. The proximal guidewire port may be closer to the distal guidewire port than the proximal end of the second elongate shaft.


In still another aspect of the present invention, a method for treating a bifurcated vessel having a main branch and a side branch in patient comprises providing a first delivery catheter and a second delivery catheter. The first delivery catheter comprises a proximal expandable member, a distal expandable member and a first stent. The proximal and distal expandable members are disposed near a distal end of the first delivery catheter. The first stent comprises a proximal stent and a distal stent. The proximal stent is disposed over the proximal expandable member, and the distal stent is disposed over the distal expandable member. A distal portion of the proximal stent comprises a notched region, and a proximal portion of the distal stent comprises a notched region. The two notched regions are adjacent one another to form a side hole in the first stent.


The second delivery catheter comprises a second expandable member and a second stent. The second expandable member is disposed near a distal end of the second delivery catheter, and the second stent is disposed over the second expandable member. The second delivery catheter passes through the side hole in the first stent. Advancing the first and the second delivery catheter positions the two catheters toward the bifurcation so that the side hole in the first stent may be aligned with the side branch. The second stent is radially expanded from a collapsed configuration to an expanded configuration. The proximal stent is radially expanded from a collapsed configuration to an expanded configuration, and the distal stent is radially expanded from a collapsed configuration to an expanded configuration.


Advancing the first and the second delivery catheters may comprise advancing the first delivery catheter or the second delivery catheter over a guidewire. Aligning the side hole may comprise advancing the first delivery catheter and the second delivery catheter until one or more of the delivery catheters engage a carina of the bifurcation.


Radially expanding the second stent may comprise expanding the second stent to engage a wall of the side branch or a wall of the main branch. Radially expanding the second stent may also comprise expanding the second expandable member. The second expandable member may comprise a balloon, and expanding the second expandable member may comprise inflating the balloon. The second stent may be radially expanded prior to radial expansion of the proximal stent or the distal stent.


Radially expanding the proximal stent may comprise expanding the proximal stent to engage a wall of the main branch. Radially expanding the proximal stent may also comprise expanding the proximal expandable member. The proximal expandable member may comprise a balloon, and expanding the proximal expandable member may comprise inflating the balloon. The proximal stent may be radially expanded before radial expansion of the distal stent.


Radially expanding the distal stent may comprise expanding the distal stent to engage a wall of the main branch or a wall of the side branch. Radially expanding the distal stent may also comprise expanding the distal expandable member. The distal expandable member may comprise a balloon, and expanding the distal expandable member may comprise inflating the balloon.


The method may further comprise proximally retracting the second delivery catheter so that a proximal end of the second stent is aligned with the side hole in the first stent. A proximal end of the second stent may be aligned with an ostium of the side branch. Proximally retracting the second delivery catheter may comprise aligning a radiopaque maker on the second delivery catheter with a radiopaque marker on the first delivery catheter. Proximally retracting the second delivery catheter may comprise sliding the second delivery catheter under a portion of the first stent. The second delivery catheter may slide under a portion of the proximal stent or under a portion of the distal stent. Proximally retracting the second delivery catheter may comprise sliding the second delivery catheter through the side hole in the first stent. A proximal portion of the second stent may abut both a distal portion of the proximal stent and a proximal portion of the distal stent after radial expansion of the proximal stent, the distal stent, and the second stent. The distal portion of the proximal stent may abut the proximal portion of the distal stent after radial expansion of the stents.


In still another aspect of the present invention, a method for treating a bifurcated vessel having a main branch and a side branch in a patient comprises providing a first delivery catheter and a second delivery catheter. The first delivery catheter comprises a proximal expandable member, a distal expandable member and a first stent. The proximal and distal expandable members are disposed near a distal end of the first delivery catheter. The first stent comprises a proximal stent and a distal stent. The proximal stent is disposed over the proximal expandable member, and the distal stent is disposed over the distal expandable member. A distal portion of the proximal stent comprises a notched region, and a proximal portion of the distal stent comprises a notched region. The notched regions are adjacent one another to form a side hole in the first stent.


The second delivery catheter comprises a second expandable member and a second stent. The second expandable member is disposed near a distal end of the second delivery catheter, and the second stent is disposed over the second expandable member. The second delivery catheter passes through the side hole in the first stent. Advancing the first and second delivery catheters positions them toward the bifurcation. The first stent and the second stent are positioned at the bifurcation such that the proximal stent is disposed in the main branch, the distal stent is disposed in the side branch, and the second stent is disposed in the main branch downstream of the bifurcation. The side hole in the first stent is aligned with the main branch and faces downstream of the bifurcation. The distal stent is radially expanded from a collapsed configuration to an expanded configuration. The proximal stent is radially expanded from a collapsed configuration to an expanded configuration. The second stent is radially expanded from a collapsed configuration to an expanded configuration.


In yet another aspect of the present invention, a method for treating a bifurcated vessel having a main branch and a side branch in a patient comprises providing a first delivery catheter and a second delivery catheter. The first delivery catheter comprises a proximal expandable member and a distal expandable member. The proximal and distal expandable members are disposed near a distal end of the first delivery catheter, and the expandable members are independently expandable from one another. The second delivery catheter comprises a second expandable member disposed near a distal end thereof. The first and second delivery catheters are advanced toward the bifurcation and the second expandable member is positioned in the side branch. The proximal and distal expandable members are positioned in the main branch so that the proximal expandable member is at least partially upstream of the bifurcation, and the distal expandable member is at least partially downstream of the bifurcation. The second expandable member is radially expanded from a collapsed configuration to an expanded configuration. The proximal expandable member is radially expanded from a collapsed configuration to an expanded configuration. The distal expandable member is radially expanded from a collapsed configuration to an expanded configuration.


Radially expanding the second expandable member may comprise expanding the second expandable member into engagement with a wall of the side branch or the main branch. The second expandable member may comprise a balloon, and expanding the second expandable member may comprise inflating the balloon. The second expandable member may be expanded prior to radial expansion of the proximal expandable member or the distal expandable member.


Radially expanding the proximal expandable member may comprise expanding the proximal expandable member to engage a wall of the main branch. The proximal expandable member may comprise a balloon, and expanding the expandable member may comprise inflating the balloon. The proximal expandable member may be expanded before radial expansion of the distal expandable member, or before expansion of the second expandable member. The proximal expandable member may also be expanded simultaneously with the distal expandable member, the second expandable member, or simultaneously with both.


Radially expanding the distal expandable member may comprise expanding the distal expandable member to engage a wall of the main branch or the side branch. The distal expandable member may comprise a balloon, and expanding the distal expandable member may comprise inflating the balloon. The distal expandable member may be expanded before expansion of the proximal expandable member or second expandable member.


The method may further comprise proximally retracting the second delivery catheter so that a proximal end of the second expandable member is aligned with an ostium of the side branch. Proximally retracting the second delivery catheter may comprise sliding the second delivery catheter under a portion of the proximal expandable member. Both the proximal and distal expandable members may be radially expanded simultaneously. A proximal portion of the distal expandable member may engage a distal portion of the proximal expandable member.


In still another aspect of the present invention, a method for treating a bifurcated vessel having a main branch and a side branch in a patient comprises providing a first delivery catheter and a second delivery catheter. The first delivery catheter comprises a proximal expandable member and a distal expandable member. The proximal and distal expandable members are disposed near a distal end of the first delivery catheter. The proximal and the distal expandable members are independently expandable from one another. The second delivery catheter comprises a second expandable member disposed near a distal end thereof. The first and second delivery catheters are advanced toward the bifurcation, and the proximal expandable member is positioned in the main branch adjacent the bifurcation. The distal expandable member is positioned in the side branch adjacent the bifurcation. The second expandable member is positioned in the main branch downstream of the proximal expandable member. The distal expandable member is radially expanded from a collapsed configuration to an expanded configuration. The proximal expandable member is radially expanded from a collapsed configuration to an expanded configuration. The second expandable member is radially expanded from a collapsed configuration to an expanded configuration.


In yet another aspect of the present invention, a system for treating a patient with a trifurcated vessel having a main branch, a first side branch, and a second side branch comprises a first delivery catheter, a second delivery catheter and a third delivery catheter. The first delivery catheter carries a first stent. The first stent comprises a proximal stent and a distal stent. The first delivery catheter also has a proximal elongate shaft with a proximal and a distal end, and a distal elongate shaft with a proximal and distal end. The proximal elongate shaft comprises a proximal expandable member with the proximal stent disposed thereover, and the distal elongate shaft comprises a distal expandable member with the distal stent disposed thereover. The proximal and distal expandable members are disposed adjacent the distal end of the first delivery catheter. The proximal and distal expandable members each have a collapsed configuration and a radially expanded configuration. The collapsed configuration has a profile suitable for advancement through a blood vessel, and the expanded configuration has a larger profile than the collapsed configuration profile. The proximal and distal expandable members are independently expandable of one another. The second delivery catheter carries a second stent, and also has a second elongate shaft with a proximal and a distal end, and a second expandable member with the second stent disposed thereover. The second expandable member is disposed adjacent the distal end of the second elongate shaft. The second expandable member has a collapsed configuration and a radially expanded configuration. The collapsed configuration has a profile suitable for advancement through a blood vessel, and the expanded configuration has a larger profile than the profile in the collapsed configuration. The second expandable member is independently expandable of the proximal and the distal expandable members. The third delivery catheter carries a third stent. The third delivery catheter also has a third elongate shaft with a proximal and a distal end, and a third expandable member with the third stent disposed thereover. The third expandable member is disposed adjacent the distal end of the third elongate shaft. The third expandable member has a collapsed configuration and a radially expanded configuration. The collapsed configuration has a profile suitable for advancement through a blood vessel, and the expanded configuration has a larger profile than the profile in the collapsed configuration. The third expandable member is independently expandable of the second expandable member, and the proximal and the distal expandable members.


These and other embodiments are described in further detail in the following description related to the appended drawing figures.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 illustrates an exemplary embodiment of a system for treating a bifurcation.



FIG. 2 illustrates an exemplary embodiment of a stent delivery system for treating a bifurcation.



FIG. 3A illustrates a perspective view of two notched stents that form a side hole.



FIG. 3B illustrates a flat, unrolled view of the stents in FIG. 3A.



FIG. 3C illustrates a perspective view of a side hole formed by notching one stent in a pair of adjacent stents.



FIGS. 3D-3E illustrate how various stent geometries may conform to a bifurcated vessel.



FIGS. 4A-4J illustrate an exemplary method of treating a bifurcation.



FIG. 5 illustrates another exemplary method of treating a bifurcation.



FIGS. 6A-6J illustrate an exemplary method of stenting a bifurcation.



FIG. 7 illustrates another exemplary method of stenting a bifurcation.



FIG. 8 illustrates an exemplary balloon configuration.



FIGS. 9A-9B illustrate an alternative embodiment of a balloon configuration.



FIGS. 10A-10B illustrate an exemplary embodiment of stent delivery system for treating trifurcated vessels.





DETAILED DESCRIPTION OF THE INVENTION

The present invention relates to medical devices and methods, and more particularly to stent and dilatation delivery systems for treating bifurcated vessels having a main branch and a side branch. However, this is not intended to be limiting, and one of skill in the art will appreciate that the devices and methods described herein may be used to treat other regions of the body.


The scientific community is slowly moving away from a main branch vs. side branch model and nomenclature. It is now well accepted that a “mother” vessel bifurcates into two “daughter vessels,” that are anatomically after the carina. The vessel that appears to be the continuation of the mother vessel is usually less angulated. The other vessel may be commonly referred to as the side branch, or a daughter vessel. Therefore, in this specification, the terms “main branch,” “trunk,” or “mother vessel” may be used interchangeably. Also in this specification, the terms “side branch vessel” and “daughter vessel” may also be used interchangeably. The terms “main branch stent,” “trunk stent,” or “mother stent” are interchangeable, and the term “side branch stent” is also interchangeable with the term “daughter stent.” In the case where a main branch vessel bifurcates into two equally sized branches, one of the branches may still be considered to be the main branch or mother vessel, and the other branch may be considered a side branch or daughter vessel.


Systems for Treating a Bifurcation


Referring now to FIG. 1, a system 100 for treating bifurcations comprises a first catheter 101 and a second catheter 125. The first catheter includes a first elongate shaft 102 having a proximal region 104 and a distal region 112. A proximal expandable member, here a balloon 108, and a distal expandable member, also a balloon 110 are disposed near the distal region of the first catheter 101. A gap 113 separates the proximal expandable member 108 from the distal expandable member 110. The proximal expandable member is disposed on the first elongate shaft 102, and the distal expandable member 110 is disposed over an extended portion 112 of the first shaft 102. The extended portion 112 may be a stepped down, reduced diameter portion of the first shaft 102, or it may be a separate shaft that is coupled with the first shaft 102. The extended portion may also be a coextruded shaft that extends parallel to the first shaft. The extended portion 112 may be fixed relative to the first shaft 102, or it may also be slidably movable relative to the first shaft 102. Proximal 114a and distal 114b radiopaque markers may be disposed adjacent the distal expandable member 110 in order to allow a physician to visualize balloon location during fluoroscopy. Similarly, proximal 129a and distal 129b radiopaque markers may be disposed adjacent the proximal balloon 108. The markers are preferably positioned at the proximal and distal working ends of the respective balloon. An inflation lumen (not illustrated) allows the balloon 110 to be inflated from the proximal end of the first catheter. A guidewire lumen 118 extends from a distal port 115 at the distal end of the extension shaft to the proximal portion of the catheter and terminates in a Y-connector 120 having two ports 122, 124 with fittings such as Luer fittings. The Luer fittings may be used to fluidly couple the catheter with a balloon inflation device such as an Indeflator, a syringe, medical tubing, or other devices commonly used during a catheterization procedure. The guidewire lumen 118 is coupled with port 122, and thus the first catheter may be delivered over a guidewire GW which slidably passes from the distal port 115, through the extended portion 112, though the first catheter 102, and exits proximal port 122. This configuration is commonly referred to as an over-the-wire configuration. While not illustrated, one of skill in the art will also appreciate that the proximal guidewire port may also be located anywhere along the first delivery catheter, and in some preferred embodiments the proximal port 122 is located closer to the distal port 115 than the proximal end of the first catheter. This configuration is commonly referred to as Rx, or rapid exchange configuration. Both balloons may be inflated independently of one another, and thus balloon 108 has its own inflation lumen (not illustrated) which is passes through the first elongate shaft 102 and terminates at hub 116 which has a fitting such a Luer fitting to allow an inflation device such as an Indeflator to be fluidly coupled to the catheter. Both the proximal and distal expandable members may be expanded from a collapsed configuration having a low profile suitable for intravascular delivery to a target treatment site such as a bifurcated vessel, to a radially expanded configuration in which the balloons engage the walls of the target treatment site, such as a blood vessel wall.


The second catheter 125 also has an elongate shaft 126 having a proximal portion and a distal portion. An expandable member 134, here a balloon, is disposed on the elongate shaft 126, near it's distal end. A proximal 136a and distal 136b radiopaque marker may be coupled to the shaft 126 and aligned with the balloon 134 so that a physician may visualize the balloon under fluoroscopy. The radiopaque markers 136a, 136b are preferably located at the proximal and the distal working ends of the balloon 134. A proximal connector 130 is coupled to the proximal end of the shaft 126 and allows a syringe, inflation device, medical tubing, or other device to be fluidly coupled with an inflation lumen (not shown) which extends along the elongate shaft 126 and is fluidly coupled to the expandable member 134. A guidewire lumen 128 extends from a distal port 135 to a proximal port 132. In preferred embodiments, the proximal port 132 is closer to the distal port 135 than the proximal end of the elongate shaft 126. This configuration is often referred to as Rx or rapid exchange. The guidewire lumen may also optionally extend out the proximal end of the shaft to provide a catheter having what is commonly referred to as an over-the-wire configuration. In preferred embodiments, shaft 126 may extend slidably through a lumen 106 in the shaft 102 of the first catheter 101 so that the balloon 134 may be advanced or retracted relative to the distal balloon 110. In other embodiments, shaft 126 may be fixedly attached to shaft 102 with no relative movement between the two catheters. Balloon 134 may be expanded from a collapsed configuration having a low profile suitable for intravascular delivery to a target treatment site such as a bifurcated vessel, to a radially expanded configuration in which the balloons engage the walls of the target treatment site, such as a blood vessel wall. Any of the balloons 108, 110, 134 may be compliant, non-compliant, or semi-compliant. Moreover, any of the balloons 108, 110, 134 may have a substantially constant diameter, or they may be tapered to match the contours of a vessel. In preferred embodiments, the balloons are tapered and non-compliant.



FIG. 2 illustrates another catheter system 200 for treating a bifurcation. In this exemplary embodiment, catheter system 200 is similar to the system 100 of FIG. 1, with the major difference being that system 100 also includes three stents 152, 154, 158.


The first catheter carries a first stent which is comprised of two discrete stents, a proximal stent 152 is disposed over the proximal balloon 108 on the first catheter 101, and a distal stent 154 is disposed over the distal balloon 110. A proximal end of the distal stent 154 abuts with a distal end of the proximal stent 108. The abutting ends of the two stents are formed so that when the two stents abut one another, a side hole 156 is created, allowing the second elongate shaft 126 to pass therethrough. Exemplary embodiments of the stent side hole are disclosed in greater detail below. The side hole 156 is preferably disposed about midway between the proximal and distal stents 152, 154, however, by changing stent lengths or by further modifying the abutting ends of the stents, the side hole may be disposed anywhere between the ends of the two stents 152, 154. A second stent 158, comprised of a single stent is disposed over balloon 134 on the second delivery catheter. Other aspects of delivery system 200 generally take the same form as those previously described above with respect to catheter system 100. The stents 152, 154, 158 are preferably balloon expandable, but may also be self-expanding, or combinations of balloon expandable and self-expanding. The stents 152, 154, 158 are radially expandable from a collapsed or crimped configuration having a profile adapted for intravascular delivery through a vessel, to an expanded configuration in which the stents engage and provide support for a target tissue such as a vessel wall. The stents may have any length, and in preferred embodiments, the proximal stent 152, and the distal stent 154 are substantially the same length. One of skill in the art will appreciate that this is not intended to be limiting, and stent length is dependent upon the length of the target tissue being treated.



FIG. 3A illustrates a perspective view of the two stents 152, 154 in FIG. 2, with the delivery catheter removed for clarity. A proximal portion of distal stent 154 includes a notched region 154a, and similarly a distal portion of the proximal stent 152 also includes a notched portion 152a. The notched regions may be sized so that when the proximal portion of stent 154 abuts with the distal portion of stent 152, the two notched regions form a side hole 156 through which the second catheter 126 may pass. FIG. 3B illustrates the stents 152, 154 in the unrolled, flattened configuration to more clearly illustrate how the notched region may be cut into the stent. In this exemplary embodiment, the notched region is half of an ellipse, but in other embodiments, the notched region may be circular, rectangular, or other shapes may be employed. Also, in still other embodiments, the notch may be cut out of only one of the two abutting stents. FIG. 3C illustrates an exemplary embodiment of two stents 152, 154 that form a side hole 156 when the two stents abut one another. In this embodiment, a single notch 154a is cut out of only one of the stents, here stent 154 in this embodiment, although the notch could also be cut out of stent 152.


For conventional cylindrical stents 175 having orthogonal ends, placement in a side branch may result in a region 178 of the side branch that is remains unscaffolded, as seen in FIG. 3D. Providing a stent 180 having a beveled end 182 may allow the stent to more accurately conform to the side branch anatomy, thereby providing more uniform scaffolding as seen in FIG. 3E.


Methods of Treating a Bifurcation



FIGS. 4A-4J illustrate an exemplary method of treating a bifurcated vessel using the system 100 of FIG. 1. FIG. 4A illustrates the basic anatomy of stenotic lesion at a bifurcated vessel. The blood vessel BV includes a main branch MB and a side branch SB. At the bifurcation B, the vessel bifurcates into the side branch SB and a downstream portion of the main branch MB. The carina C is a keel-shaped ridge, process, or anatomical part of the bifurcation. A stenotic lesion L such as plaque, calcified deposits, or other narrowing material is disposed in the side branch, as well as in the main branch upstream and downstream of the bifurcation. The ostium O is the opening from the main branch MB into the side branch SB.


In FIG. 4B a guidecatheter or introducer catheter IC is introduced into the patient's vasculature, preferably percutaneously, or via cutdown. The introducer catheter IC is then advanced toward the target treatment area at the bifurcation. Two guidewires GW are then advanced through the introducer catheter. One guidewire is further advanced into the side branch SB past the side branch lesion L, and the other guidewire is advanced further into the main branch downstream of the main branch lesion L.



FIG. 4C shows the bifurcation treatment system 100 of FIG. 1 being advanced through the introducer catheter IC, over both guidewires GW. Both catheters 101, 125 are advanced distally until they engage the carina C, resisting further distal advancement. Both catheters may be advanced slightly distally, or retracted slightly proximally such that the first catheter 101 is positioned in the main branch MB with the proximal balloon 108 at least partially upstream of the bifurcation B, and the distal balloon 110 is at least partially downstream of the bifurcation B. Both balloons 108, 110 of course will be aligned with the lesion L in the main branch MB. The second catheter 125 is positioned in the side branch SB, preferably such that balloon 134 is slightly distal to the side branch lesion L.



FIG. 4D illustrates an optional step wherein the second catheter 125 is proximally retracted through a lumen (not shown) in the first catheter 101 so that proximal radiopaque marker 136a on the second catheter 125 is aligned with proximal radiopaque marker 129a on the first catheter 101. This may be seen in the partial cutaway in FIG. 4D. Thus, a portion of shaft 126 slides under proximal balloon 108 and through the shaft 102 of the first catheter 101. Furthermore, this ensures alignment of balloon 134 with the side branch lesion L, with the ostium of the side branch, and with the proximal 108 and distal 110 balloons. This aspect of the procedure, as well as any other aspect of the procedure may be visualized using fluoroscopy, ultrasound, or other imaging techniques suitable for catheterization procedures.


Once the balloons on both catheters are properly aligned with the lesion, the bifurcation, and with one another, the balloons may be radially expanded in any order in order to treat the lesion L. FIG. 4E illustrates a preferred first inflation wherein the balloon 134 on the second catheter 125 is expanded against the lesion L in the side branch SB. The balloon 134 may be inflated with saline, contrast media, combinations thereof, or with other fluids. The balloons are inflated to a pressure high enough to compact the plaque into the vessel wall, preferably greater than 10 atmospheres, more preferably 10 to 20 atmospheres, and even more preferably 15 to 25 atmospheres. Of course, one of skill in the art will appreciate that this pressure is not limiting, and a physician may inflate the balloon to any desired pressure. After the balloon is inflated once, or twice, or more, it is deflated, and the plaque will be substantially reduced since it is pressed into the vessel wall, thereby reducing the stenotic lesion L.



FIG. 4F illustrates another preferred step, wherein the proximal balloon 108 is expanded next, after expansion of the balloon 134 in the side branch SB. The proximal balloon may be inflated with similar fluids and pressures as previously described above. This reduces the plaque in the main branch near the bifurcation, and upstream of the bifurcation. FIG. 4G illustrates the next preferred step wherein the distal balloon 110 is expanded using similar fluids and pressures as described above. Expansion of both proximal 108 and distal 110 balloons is a modified “kissing” balloon technique. Even though the balloons 108, 110 are separated by a gap, after inflation, the proximal end of the distal balloon 110 expands toward and abuts the distal end of the proximal balloon 108 which also advances toward the other balloon. Additional details on this are disclosed below in FIGS. 8 and 9A-9B. Expanding both the proximal and distal balloons 108, 110 ensures that the lesion L in the main branch, both upstream and downstream of the bifurcation is uniformly dilated. Optionally, the side branch balloon 134 may also be simultaneously expanded (not illustrated) so that all three balloons “kiss” one another.


After the lesion has been successfully dilated, both proximal and distal balloons 108, 110 (and side branch balloon 134, if also expanded) are deflated as illustrated in FIG. 4H. In FIG. 4I, both catheters 101, 125 are proximally retracted away from the bifurcation, and removed from the patient's body. Finally, in FIG. 4J, both guidewires GW and the introducer guidecatheter IC are also proximally retracted away from the bifurcation and removed from the patient's body. The blockage in the lumen is now substantially reduced, thereby improving blood flow across the bifurcation.


The exemplary method described above is not intended to be limiting. One of skill in the art will appreciate that a number of variations or changes may also be made. For example, any one or more of the balloons may be coated with a therapeutic agent such as an anti-restonois drug like rapamycin, everolimus, biolimus A9, other analogs of rapamycin, or paclitaxel to help reduce restenosis. Moreover, any order or combination of balloon inflation may also be used. For example, the proximal and distal balloons may be expanded prior to expansion of the side branch balloon, or the distal balloon maybe inflated before the proximal balloon. Other variations may include simultaneous inflation of the side branch balloon with the proximal balloon, or simultaneous inflation of the side branch balloon and the distal balloon. Any number of permutations are contemplated.


Additionally, in an alternative embodiment shown in FIG. 5, the distal balloon 110 of the first catheter 101 may be advanced into the side branch SB while the proximal balloon 108 remains in the main branch MB. The balloon 134 on the second catheter 125 may then be advanced into the main MB branch at least partially downstream of the bifurcation. Inflation of the balloons may follow any of the number of permutations discussed above.



FIGS. 6A-6J illustrate an exemplary method of stenting a bifurcation using the delivery system 200 previously described in FIG. 2 above. FIG. 6A illustrates the basic anatomy of stenotic lesion at a bifurcated vessel. The blood vessel BV includes a main branch MB and a side branch SB. At the bifurcation B, the vessel bifurcates into the side branch SB and a downstream portion of the main branch MB. The carina C is a keel-shaped ridge, process, or anatomical part of the bifurcation. A stenotic lesion L such as plaque, calcified deposits, or other narrowing material is disposed in the side branch, as well as in the main branch upstream and downstream of the bifurcation. The ostium O is the opening from the main branch MB into the side branch SB.


In FIG. 6B a guidecatheter or introducer catheter IC is introduced into the patient's vasculature, preferably percutaneously, or via cutdown. The introducer catheter IC is then advanced toward the target treatment area at the bifurcation. Two guidewires GW are then advanced through the introducer catheter. One guidewire is further advanced into the side branch SB past the side branch lesion L, and the other guidewire is advanced further into the main branch downstream of the main branch lesion L.



FIG. 6C shows the bifurcation treatment system 200 of FIG. 2 being advanced through the introducer catheter IC, over both guidewires GW. Both catheters 101, 125 are advanced distally until they engage the carina C, resisting further distal advancement. Both catheters may be advanced slightly distally, or retracted slightly proximally such that the first catheter 101 is positioned in the main branch MB with the proximal stent 152 at least partially upstream of the bifurcation B, and the distal stent 154 is at least partially downstream of the bifurcation B. Both stents 152, 154 of course will be aligned with the lesion L in the main branch MB. Furthermore, the notched regions 152a, 154a forming the side hole 156 will also be aligned with the ostium to the side branch. The second catheter 125 is positioned in the side branch SB, preferably such that stent 158 is slightly distal to the side branch lesion L. In this embodiment, the stents 152, 154, 158 are preferably balloon expandable. However, they may also be self-expanding, or combinations of balloon expandable and self-expanding.



FIG. 6D illustrates an optional step wherein the second catheter 125 is proximally retracted through a lumen (not shown) in the first catheter 101 so that proximal radiopaque marker 136a on the second catheter 125 is aligned with proximal radiopaque marker 129a on the first catheter 101. This may be seen in the partial cutaway in FIG. 6D. Thus, a portion of shaft 126 slides under proximal balloon 108, under proximal stent 152, and through the shaft 102 of the first catheter 101. Furthermore, this ensures alignment of stent 158 with the side branch lesion L, with the ostium of the side branch, and with the proximal 152 and distal 154 balloons. This aspect of the procedure, as well as any other aspect of the procedure may be visualized using fluoroscopy, ultrasound, or other imaging techniques suitable for catheterization procedures.


Once the stents on both catheters are properly aligned with the lesion, the bifurcation, and with one another, the balloons may be radially expanded thereby expanding the stents to treat the lesion. FIG. 6E illustrates a preferred first inflation wherein the balloon 134 on the second catheter 125 is expanded, thereby expanding stent 158 into the lesion L in the side branch SB. The balloon 134 may be inflated with saline, contrast media, combinations thereof, or with other fluids. The balloons are inflated to similar pressures as those previously described above. Of course, one of skill in the art will appreciate that these pressures are not limiting, and a physician may inflate the balloon to any desired pressure. After the stent is expanded into the lesion, the balloon 134 is deflated. A second post-dilation may also be performed if necessary to further tack the stent into position.



FIG. 6F illustrates another preferred step, wherein the proximal balloon 108 is expanded next so as to radially expand the proximal stent 152 into the lesion L around the lesion and slightly upstream of the bifurcation. Expansion of stent 152 is performed after expansion of stent 158 in the side branch SB. The proximal balloon may be inflated with similar fluids and pressures as previously described above. FIG. 6G illustrates the next preferred step wherein the distal balloon 110 is expanded using similar fluids and pressures as described above, thereby expanding distal stent 154. The distal balloon is inflated while the proximal balloon is inflated. Expansion of both proximal 108 and distal 110 balloons is a modified “kissing” balloon technique. Even though the balloons 108, 110 are separated by a gap, after inflation, the proximal end of the distal balloon 110 expands toward and abuts the distal end of the proximal balloon 108 which also advances toward the other balloon. Additional details on this are disclosed below in reference to FIGS. 8, and 9A-9B. This helps ensure that the distal end of the proximal stent 152 abuts the proximal end of the distal stent 154, and that the side hole 156 abuts the proximal end of the side branch stent 158, thereby ensuring that the stent fully covers and scaffolds the bifurcation. Additionally, expanding both the proximal and distal balloons 108, 110 ensures that the proximal and distal stents 152, 154 are expanded uniformly in the main branch, both upstream and downstream of the bifurcation. Optionally, the side branch balloon 134 may also be simultaneously expanded (not illustrated) so that all three balloons “kiss” with one another.


After the lesion has been successfully stented, both proximal and distal balloons 108, 110 (and side branch balloon 134, if also expanded) are deflated as illustrated in FIG. 6H. In FIG. 6I, both catheters 101, 125 are proximally retracted away from the bifurcation, and removed from the patient's body. Finally, in FIG. 6J, both guidewires GW and the introducer guidecatheter IC are also proximally retracted away from the bifurcation and removed from the patient's body. The blockage in the lumen is now substantially reduced and scaffolded, thereby improving blood flow across the bifurcation.


The exemplary method described above is not intended to be limiting. One of skill in the art will appreciate that a number of variations or changes may also be made. For example, any one or more of the balloons, stents, or combinations of balloons/stents may be coated with a therapeutic agent such as an anti-restonois drug like rapamycin, everolimus, biolimus A9, other analogs of rapamycin, or paclitaxel to help reduce restenosis. Moreover, any order or combination of balloon/stent expansion may be employed. For example, the proximal and distal balloons/stents may be expanded prior to expansion of the side branch balloon/stent, or the distal balloon/stent may be inflated before the proximal balloon/stent. Other variations may include simultaneous expansion of the side branch balloon/stent with the proximal balloon/stent, or simultaneous inflation of the side branch balloon/stent and the distal balloon/stent. Any number of permutations are contemplated.


Additionally, in an alternative embodiment shown in FIG. 7, the distal stent 154 of the first catheter 101 may be advanced into the side branch SB while the proximal stent 152 remains in the main branch MB. The stent 158 on the second catheter 125 may then be advanced into the main MB branch at least partially downstream of the bifurcation. Inflation of the balloons may follow any of the number of permutations discussed above.


Exemplary Balloon Configurations



FIG. 8 illustrates one exemplary balloon configuration that may be used in any of the systems or method described above. Catheter shaft 302 includes a proximal balloon 304 and a distal balloon 306 coupled to the shaft 302. Both proximal and distal balloons 304, 306 have standard proximal tapers 308 and distal tapers 310. The tapered regions 308, 310 allow the balloon to be fixedly coupled to shaft 302 with a fluid tight seal. This may be accomplished by ultrasonic welding, adhesively bonding, suture wrapping, or other techniques known to those in the art. While this configuration is promising, the gap 308 separating the proximal and distal balloons 304, 306 will remain even after both balloons are inflated. Thus, a section of the vessel may remain undilated, or unstented, which is not optimal.



FIG. 9A illustrates another exemplary balloon configuration that may overcome some of the shortcomings of the previous embodiment. Shaft 302 includes a proximal balloon 304a and a distal balloon 306a. The proximal end 312a and the distal end 314a of each balloon is everted and attached to the shaft using similar techniques as those described above. In the unexpanded configuration of FIG. 9A, a gap 308 still exists when the balloons are uninflated. However, when both balloons 304a, 306a are inflated, because of the everted ends, the proximal end of each balloon will tend to move proximally, and the distal end of each balloon will also tend to move distally, as indicated by the arrows. Thus, the distal end of the proximal balloon 304a will move toward and abut the proximal end of the distal balloon 306a. This reduces or eliminates the gap 308 between the two balloons. Therefore, the vessel will be more uniformly dilated or stented. Also, in the case where stents are mounted over the balloons, the ends of the stents will also tend to move toward one another, therefore the gap between adjacent stents will also tend to close resulting in more uniform stenting.


Exemlary Stent Delivery Systems for Treating Trifucations


The embodiments described above are preferably used to treat bifurcated vessels. However, the basic embodiment may be expanded upon in order to treat trifurcated vessels such that those with a main branch and two side branches. FIGS. 10A-10B illustrate one exemplary embodiment of a stent delivery system that may be used to stent a trifurcated vessel. Stent delivery system 1002 includes a first side branch stent delivery catheter 1004 and a second side branch stent delivery catheter 1006. Also, the main branch stent delivery catheter includes a proximal balloon 1012 with a stent 1010 disposed thereover, and a distal balloon with a stent 1018 disposed thereover and coupled to a central shaft 1008. The central shaft includes at least three lumens sized to accommodate the shafts of the first and second side branch catheters, and the main branch shaft. The shafts may be slidable disposed in the lumens, or they may be fixed. The first side branch stent delivery catheter includes a balloon 1030 and stent 1031 disposed thereover near the catheter distal end. It is disposed in a rapid exchange lumen of the main shaft such that the proximal port 1026 is closer to the distal end of the catheter than the proximal end of the catheter. The second side branch catheter is similarly configured and includes a balloon 1032 and a stent 1033 disposed thereover adjacent the distal end of the catheter. The second side branch catheter is disposed in a rapid exchange lumen of the main shaft such that the proximal port is closer to the distal end of the catheter than the proximal end. The main branch catheter includes proximal balloon 1012 having a proximal taper 1016 and a distal everted end 1014 that allows the distal end of the balloon to expand distally toward the distal main branch balloon upon inflation. In alternative embodiments, both ends of balloon 1012 may be tapered, everted, or th eproxima end may be everted and the distal end may be tapered. The distal main branch balloon preferably includes a distal taper 1020 and a proximal everted end 1022 that moves proximally toward the proximal main branch balloon upon inflation. A gap 1034 separates the proximal main branch stent from the distal main branch stent, thereby creating a space for the first and second side branch catheters to extend therepast. The gap may be created with the notches or other stent geometries previously described above, with the exception that two notches are required to form two gaps. During delivery, the two side branch catheters may be slidably disposed in the lumens of the main branch catheter. Upon reaching the target trifurcated vessel, the two side branch catheters may be distally extended from the lumens and exposed, passing through the gap 1034 between the proximal and distal main branch stents. The balloons may be independently inflatable thereby allowing inflation in any order to deploy stents upstream and downstream of the trifurcation, and in the two sidebranches. Kissing balloons may also be used. In an alternative embodiments, one or more of the balloons may not include a stent, and thus the a portion of the trifurcation may be dilated and a portion of the trifurcation may be stented.


While the above is a complete description of the preferred embodiments of the invention, various alternatives, modifications, and equivalents may be used. Therefore, the above description should not be taken as limiting the scope of the invention which is defined by the appended claims.

Claims
  • 1. A method for treating a bifurcated vessel, said method comprising: providing a first delivery catheter having a proximal end, a distal end, a proximal expandable member, a distal expandable member, a proximal stent and a distal stent, wherein the proximal and distal expandable members are disposed adjacent the distal end of the first delivery catheter, and wherein the proximal stent is disposed on the proximal expandable member and the distal stent is disposed on the distal expandable member;providing a second delivery catheter having a proximal end, a distal end and a second expandable member disposed adjacent the distal end of the second delivery catheter;advancing both the first and second delivery catheters toward a lesion in the bifurcated vessel;radially expanding the proximal and distal expandable members, wherein a proximal end of the proximal expandable member and a distal end of the proximal expandable member are everted, and wherein a proximal end of the distal expandable member and a distal end of the distal expandable member are everted;advancing the distal end of the proximal expandable member distally and retracting the proximal end of the distal expandable member proximally so that the distal end of the proximal expandable member and the proximal end of the distal expandable member move toward one another;abutting a distal end of the proximal stent with a proximal end of the distal stent thereby forming a side hole in the abutted proximal and distal stents; andpassing the second delivery catheter through the side hole.
  • 2. The method of claim 1, wherein the second delivery catheter further comprises a second stent disposed on the second expandable member, the method further comprising radially expanding the second expandable member thereby radially expanding the second stent.
  • 3. The method of claim 2, wherein radially expanding the second stent comprises radially expanding the second stent in a side branch of the bifurcated vessel.
  • 4. The method of claim 2, wherein radially expanding the second stent comprises radially expanding the second stent in a main branch of the bifurcated vessel.
  • 5. The method of claim 2, wherein the second stent comprises a beveled proximal end, the method further comprising abutting the beveled proximal end with the proximal and distal stents adjacent the side hole.
  • 6. The method of claim 1, wherein radially expanding the proximal and distal expandable members comprises radially expanding the proximal and distal stents in a main branch of the bifurcated vessel.
  • 7. The method of claim 1, wherein radially expanding the proximal and distal expandable members comprises radially expanding the proximal stent in a main branch of the bifurcated vessel and radially expanding the distal stent in a side branch of the bifurcated vessel.
  • 8. The method of claim 1, wherein the proximal stent comprises a notched region adjacent a distal end thereof, and wherein the distal stent comprises a notched region adjacent a proximal region thereof, and wherein radially expanding the proximal and distal expandable members draws the notched region of the distal stent and the notched region of the proximal stent toward one another to form the side hole.
  • 9. The method of claim 1, wherein one of the proximal stent and the distal stent comprises a notched region and the other of the proximal stent and the distal stent remains unnotched in an unnotched region, and wherein radially expanding the proximal and distal expandable members draws the notched region towards the unnotched region to form the side hole.
  • 10. The method of claim 1, wherein the proximal expandable member and the distal expandable member are radially expanded concurrently.
CROSS REFERENCE TO RELATED APPLICATION DATA

The present application is a continuation of U.S. patent application Ser. No. 14/971,615 filed on Dec. 16, 2015, which is a continuation of U.S. patent application Ser. No. 13/796,466, filed on Mar. 12, 2013 now U.S. Pat. No. 9,254,210, which is a continuation of PCT International Application No. PCT/US2012/024366 filed on Feb. 8, 2012, which is a non-provisional of and claims the benefit of U.S. Provisional Patent Application No. 61/440,742 filed on Feb. 8, 2011; the entire contents of which are incorporated herein by reference.

US Referenced Citations (563)
Number Name Date Kind
4069825 Akiyama Jan 1978 A
4468224 Enzmann et al. Aug 1984 A
4512338 Balko et al. Apr 1985 A
4564014 Fogarty et al. Jan 1986 A
4580568 Gianturco Apr 1986 A
4681110 Wiktor Jul 1987 A
4690684 Mcgreevy et al. Sep 1987 A
4733665 Palmar Mar 1988 A
4739762 Palmaz Apr 1988 A
4762129 Bonzel Aug 1988 A
4770176 Mcgreevy et al. Sep 1988 A
4775337 Van Wagener et al. Oct 1988 A
4776337 Palmaz Oct 1988 A
4886062 Wiktor Dec 1989 A
4891225 Langer et al. Jan 1990 A
4988356 Crittenden et al. Jan 1991 A
4994066 Voss Feb 1991 A
4994069 Ritchart et al. Feb 1991 A
5013318 Spranza, III May 1991 A
5040548 Yock Aug 1991 A
5064435 Porter Nov 1991 A
5092877 Pinchuk Mar 1992 A
5102417 Palmaz Apr 1992 A
5104404 Wolff Apr 1992 A
5122154 Rhodes Jun 1992 A
5135535 Kramer Aug 1992 A
5171222 Euteneuer et al. Dec 1992 A
5195984 Schatz Mar 1993 A
5217495 Kaplan et al. Jun 1993 A
5219355 Parodi et al. Jun 1993 A
5226913 Pinchuk Jul 1993 A
5246421 Saab Sep 1993 A
5273536 Savas Dec 1993 A
5282824 Gianturco Feb 1994 A
5300085 Yock Apr 1994 A
5312415 Palermo May 1994 A
5334187 Fischell et al. Aug 1994 A
5403341 Solar Apr 1995 A
5421955 Lau et al. Jun 1995 A
5456694 Marin et al. Oct 1995 A
5456713 Chuter Oct 1995 A
5458615 Klemm et al. Oct 1995 A
5478349 Nicholas Dec 1995 A
5490837 Blaeser et al. Feb 1996 A
5496346 Horzewski et al. Mar 1996 A
5501227 Yock Mar 1996 A
5507768 Lau et al. Apr 1996 A
5507771 Gianturco Apr 1996 A
5514093 Ellis et al. May 1996 A
5514154 Lau et al. May 1996 A
5527354 Fontaine et al. Jun 1996 A
5549551 Peacock, III et al. Aug 1996 A
5549563 Kronner Aug 1996 A
5549635 Solar Aug 1996 A
5554181 Das Sep 1996 A
5562725 Schmitt et al. Oct 1996 A
5571086 Kaplan et al. Nov 1996 A
5591228 Edoga Jan 1997 A
5593412 Martinez et al. Jan 1997 A
5607444 Lam Mar 1997 A
5607463 Schwartz et al. Mar 1997 A
5609627 Goicoechea et al. Mar 1997 A
5609629 Fearnot et al. Mar 1997 A
5628775 Jackson et al. May 1997 A
5632763 Glastra May 1997 A
5632772 Alcime et al. May 1997 A
5634928 Fischell et al. Jun 1997 A
5639274 Fischell et al. Jun 1997 A
5662675 Polanskyj et al. Sep 1997 A
5669924 Shaknovich Sep 1997 A
5670161 Healy et al. Sep 1997 A
5676654 Ellis et al. Oct 1997 A
5679400 Tuch Oct 1997 A
5683451 Lenker et al. Nov 1997 A
5697948 Marin et al. Dec 1997 A
5697967 Dinh et al. Dec 1997 A
5702418 Ravenscroft Dec 1997 A
5709701 Parodi Jan 1998 A
5716393 Lindenberg et al. Feb 1998 A
5722669 Shimizu et al. Mar 1998 A
5723003 Winston et al. Mar 1998 A
5735869 Fernandez-Aceytuno Apr 1998 A
5741323 Pathak et al. Apr 1998 A
5749848 Jang et al. May 1998 A
5749921 Lenker et al. May 1998 A
5755735 Richter et al. May 1998 A
5755771 Penn et al. May 1998 A
5755772 Evans et al. May 1998 A
5755776 Al-Saadon May 1998 A
5755781 Jayaraman May 1998 A
5769882 Fogarty et al. Jun 1998 A
5772669 Vrba Jun 1998 A
5776141 Klein et al. Jul 1998 A
5797951 Mueller Aug 1998 A
5800519 Sandock Sep 1998 A
5807398 Shaknovich Sep 1998 A
5824040 Cox et al. Oct 1998 A
5824041 Lenker et al. Oct 1998 A
5824048 Tuch Oct 1998 A
5827320 Richter et al. Oct 1998 A
5833694 Poncet Nov 1998 A
5836964 Richter et al. Nov 1998 A
5837008 Berg et al. Nov 1998 A
5843092 Heller et al. Dec 1998 A
5855563 Kaplan et al. Jan 1999 A
5858556 Eckert et al. Jan 1999 A
5870381 Kawasaki et al. Feb 1999 A
5879370 Fischell et al. Mar 1999 A
5891190 Boneau Apr 1999 A
5893887 Jayaraman Apr 1999 A
5895398 Wensel et al. Apr 1999 A
5899935 Ding May 1999 A
5902332 Schatz May 1999 A
5911754 Kanesaka et al. Jun 1999 A
5919175 Sirhan Jul 1999 A
5922020 Klein et al. Jul 1999 A
5961536 Mickley et al. Oct 1999 A
5968069 Dusbabek et al. Oct 1999 A
5972027 Johnson Oct 1999 A
5976107 Mertens et al. Nov 1999 A
5976155 Foreman et al. Nov 1999 A
5980484 Ressemann et al. Nov 1999 A
5980486 Enger Nov 1999 A
5980514 Kupiecki et al. Nov 1999 A
5980552 Pinchasik et al. Nov 1999 A
5984957 Lapewicz, Jr. et al. Nov 1999 A
5997563 Kretzers Dec 1999 A
6004328 Solar et al. Dec 1999 A
6007517 Anderson Dec 1999 A
6017363 Hojeibane Jan 2000 A
6022359 Frantzen Feb 2000 A
6022374 Imran Feb 2000 A
6033434 Borghi Mar 2000 A
6036725 Avellanet Mar 2000 A
6039721 Johnson et al. Mar 2000 A
6042589 Marianne Mar 2000 A
6048361 Von Oepen Apr 2000 A
6056722 Jayaraman May 2000 A
6056775 Borghi et al. May 2000 A
6059811 Pinchasik et al. May 2000 A
6059824 Taheri May 2000 A
6066155 Amann et al. May 2000 A
6068655 Seguin et al. May 2000 A
6070589 Keith et al. Jun 2000 A
6086604 Fischell et al. Jul 2000 A
6090063 Makower et al. Jul 2000 A
6090136 Mcdonald et al. Jul 2000 A
6096071 Yadav Aug 2000 A
6096073 Webster et al. Aug 2000 A
6099497 Adams et al. Aug 2000 A
6102942 Ahari Aug 2000 A
6106530 Harada Aug 2000 A
RE36857 Euteneuer et al. Sep 2000 E
6117117 Mauch Sep 2000 A
6120522 Vrba et al. Sep 2000 A
6123712 Di Caprio et al. Sep 2000 A
6123723 Konya Sep 2000 A
6126685 Lenker et al. Oct 2000 A
6129738 Lashinski et al. Oct 2000 A
6129756 Kugler et al. Oct 2000 A
6132460 Thompson Oct 2000 A
6136011 Stambaugh Oct 2000 A
6142973 Carleton et al. Nov 2000 A
6143016 Bleam et al. Nov 2000 A
6165167 Delaloye Dec 2000 A
6165210 Lau et al. Dec 2000 A
6179878 Duerig et al. Jan 2001 B1
6183509 Dibie Feb 2001 B1
6187034 Frantzen Feb 2001 B1
6190402 Horton et al. Feb 2001 B1
6196995 Fagan Mar 2001 B1
6200337 Moriuchi et al. Mar 2001 B1
6210429 Vardi et al. Apr 2001 B1
6231600 Zhong May 2001 B1
6238991 Suzuki May 2001 B1
6241691 Ferrera et al. Jun 2001 B1
6251132 Ravenscroft et al. Jun 2001 B1
6251134 Alt et al. Jun 2001 B1
6254612 Hieshima Jul 2001 B1
6254628 Wallace et al. Jul 2001 B1
6258117 Camrud et al. Jul 2001 B1
6258121 Yang et al. Jul 2001 B1
6264682 Wilson et al. Jul 2001 B1
6264688 Herklotz et al. Jul 2001 B1
6267783 Letendre et al. Jul 2001 B1
6273895 Pinchuk et al. Aug 2001 B1
6273911 Cox et al. Aug 2001 B1
6273913 Wright et al. Aug 2001 B1
6312458 Golds Nov 2001 B1
6315794 Richter Nov 2001 B1
6319277 Rudnick et al. Nov 2001 B1
6322586 Monroe et al. Nov 2001 B1
6325823 Horzewski et al. Dec 2001 B1
6325826 Vardi et al. Dec 2001 B1
6326826 Lee et al. Dec 2001 B1
6334871 Dor et al. Jan 2002 B1
6344053 Boneau Feb 2002 B1
6344056 Dehdashtian Feb 2002 B1
6344272 Oldenburg et al. Feb 2002 B1
6357104 Myers Mar 2002 B1
6361555 Wilson Mar 2002 B1
6375676 Cox Apr 2002 B1
6379365 Diaz Apr 2002 B1
6383171 Gifford et al. May 2002 B1
6383215 Sass May 2002 B1
6398807 Chouinard et al. Jun 2002 B1
6409753 Brown et al. Jun 2002 B1
6415696 Erickson et al. Jul 2002 B1
6419693 Fariabi Jul 2002 B1
6428811 West et al. Aug 2002 B1
6443982 Israel et al. Sep 2002 B1
6451025 Jervis Sep 2002 B1
6451050 Rudakov et al. Sep 2002 B1
6464720 Boatman et al. Oct 2002 B2
6468298 Pelton Oct 2002 B1
6468299 Stack et al. Oct 2002 B2
6485510 Camrud et al. Nov 2002 B1
6485511 Lau et al. Nov 2002 B2
6488694 Lau et al. Dec 2002 B1
6488702 Besselink Dec 2002 B1
6488703 Kveen et al. Dec 2002 B1
6511468 Cragg et al. Jan 2003 B1
6514281 Blaeser et al. Feb 2003 B1
6520986 Martin et al. Feb 2003 B2
6520987 Plante Feb 2003 B1
6520988 Colombo et al. Feb 2003 B1
6527789 Lau et al. Mar 2003 B1
6527799 Shanley Mar 2003 B2
6529549 Norrell et al. Mar 2003 B1
6530944 West et al. Mar 2003 B2
6540777 Stenzel Apr 2003 B2
6540779 Richter et al. Apr 2003 B2
6551350 Thornton et al. Apr 2003 B1
6555157 Hossainy Apr 2003 B1
6569180 Sirhan et al. May 2003 B1
6575993 Yock Jun 2003 B1
6579305 Lashinski Jun 2003 B1
6579309 Loos et al. Jun 2003 B1
6582394 Reiss et al. Jun 2003 B1
6582460 Cryer Jun 2003 B1
6585756 Strecker Jul 2003 B1
6592549 Gerdts et al. Jul 2003 B2
6592568 Campbell Jul 2003 B2
6596020 Vardi et al. Jul 2003 B2
6596022 Lau et al. Jul 2003 B2
6599296 Gillick et al. Jul 2003 B1
6599314 Mathis Jul 2003 B2
6602282 Yan Aug 2003 B1
6605062 Hurley et al. Aug 2003 B1
6605109 Fiedler Aug 2003 B2
6607553 Healy et al. Aug 2003 B1
6645517 West et al. Nov 2003 B2
6645547 Shekalim et al. Nov 2003 B1
6656212 Ravenscroft et al. Dec 2003 B2
6660031 Tran et al. Dec 2003 B2
6660381 Halas et al. Dec 2003 B2
6666883 Seguin et al. Dec 2003 B1
6676695 Solem Jan 2004 B2
6679909 Mcintosh et al. Jan 2004 B2
6685721 Kramer Feb 2004 B1
6685730 West et al. Feb 2004 B2
6689156 Davidson et al. Feb 2004 B1
6692465 Kramer Feb 2004 B2
6692483 Vardi et al. Feb 2004 B2
6699280 Camrud et al. Mar 2004 B2
6699724 West Mar 2004 B1
6702843 Brown et al. Mar 2004 B1
6706062 Vardi et al. Mar 2004 B2
6709379 Brandau et al. Mar 2004 B1
6709440 Callol et al. Mar 2004 B2
6712827 Ellis et al. Mar 2004 B2
6712845 Hossainy Mar 2004 B2
6723071 Gerdts et al. Apr 2004 B2
6736842 Healy et al. May 2004 B2
6743251 Eder Jun 2004 B1
6749628 Callol et al. Jun 2004 B1
6761734 Suhr Jul 2004 B2
6770091 Richter et al. Aug 2004 B2
6778316 Halas et al. Aug 2004 B2
6800065 Duane et al. Oct 2004 B2
6811566 Penn et al. Nov 2004 B1
6825203 Pasternak et al. Nov 2004 B2
6835203 Vardi et al. Dec 2004 B1
6837901 Rabkin et al. Jan 2005 B2
6849084 Rabkin et al. Feb 2005 B2
6852252 Halas et al. Feb 2005 B2
6855125 Shanley Feb 2005 B2
6858034 Hijlkema et al. Feb 2005 B1
6875228 Pinchasik et al. Apr 2005 B2
6878161 Lenker Apr 2005 B2
6879370 Yokoue et al. Apr 2005 B2
6884258 Vardi et al. Apr 2005 B2
6893417 Gribbons et al. May 2005 B2
6896695 Mueller et al. May 2005 B2
6908477 Mcguckin, Jr. et al. Jun 2005 B2
6918928 Wolinsky et al. Jul 2005 B2
6939376 Shulze et al. Sep 2005 B2
6945989 Betelia et al. Sep 2005 B1
6945995 Nicholas Sep 2005 B2
6949120 Kveen et al. Sep 2005 B2
6951053 Padilla et al. Oct 2005 B2
6955687 Richter et al. Oct 2005 B2
6955688 Wilson et al. Oct 2005 B2
6962602 Vardi et al. Nov 2005 B2
6989026 Richter et al. Jan 2006 B2
7005454 Brocchini et al. Feb 2006 B2
7037327 Salmon et al. May 2006 B2
7052510 Richter May 2006 B1
7090694 Morris et al. Aug 2006 B1
7101840 Brocchini et al. Sep 2006 B2
7137993 Acosta et al. Nov 2006 B2
7147655 Chermoni Dec 2006 B2
7147656 Andreas et al. Dec 2006 B2
7182779 Acosta et al. Feb 2007 B2
7192440 Andreas et al. Mar 2007 B2
7220275 Davidson et al. May 2007 B2
7241308 Andreas et al. Jul 2007 B2
7270668 Andreas et al. Sep 2007 B2
7294146 Chew et al. Nov 2007 B2
7300456 Andreas et al. Nov 2007 B2
7309350 Landreville et al. Dec 2007 B2
7314480 Eidenschink et al. Jan 2008 B2
7320702 Hammersmark et al. Jan 2008 B2
7323006 Andreas et al. Jan 2008 B2
7323009 Suhr et al. Jan 2008 B2
7326236 Andreas et al. Feb 2008 B2
7326242 Eidenschink Feb 2008 B2
7341598 Davidson et al. Mar 2008 B2
7344556 Seguin et al. Mar 2008 B2
7387639 Bourang et al. Jun 2008 B2
7445688 Suzuki et al. Nov 2008 B2
7520895 Douglas et al. Apr 2009 B2
7537609 Davidson et al. May 2009 B2
7540881 Meyer et al. Jun 2009 B2
7635383 Gumm Dec 2009 B2
7641684 Hilaire et al. Jan 2010 B2
7641685 Richter Jan 2010 B2
7695508 Der Leest et al. Apr 2010 B2
8016870 Chew et al. Sep 2011 B2
8070789 Will et al. Dec 2011 B2
8769796 Bourang et al. Jul 2014 B2
8795347 Bourang et al. Aug 2014 B2
8808347 Bourang et al. Aug 2014 B2
8821562 Bourang et al. Sep 2014 B2
8828071 Bourang et al. Sep 2014 B2
8979917 Bourang et al. Mar 2015 B2
9254210 Bourang Feb 2016 B2
9364356 Bourang Jun 2016 B2
9724218 Bourang et al. Aug 2017 B2
9730821 Bourang et al. Aug 2017 B2
9737424 Bourang et al. Aug 2017 B2
9855158 Bourang et al. Jan 2018 B2
10406010 Bourang Sep 2019 B2
20010003161 Vardi et al. Jun 2001 A1
20010020154 Bigus et al. Sep 2001 A1
20010020181 Layne Sep 2001 A1
20010039395 Mareiro et al. Nov 2001 A1
20010044595 Reydel et al. Nov 2001 A1
20010044622 Vardi et al. Nov 2001 A1
20010044632 Daniel et al. Nov 2001 A1
20010049547 Moore Dec 2001 A1
20020037358 Barry et al. Mar 2002 A1
20020091439 Baker et al. Jul 2002 A1
20020107560 Richter Aug 2002 A1
20020111671 Stenzel Aug 2002 A1
20020128706 Osypka Sep 2002 A1
20020138132 Brown Sep 2002 A1
20020143382 Hijlkema Oct 2002 A1
20020151924 Shiber Oct 2002 A1
20020151955 Tran et al. Oct 2002 A1
20020156496 Chermoni Oct 2002 A1
20020173835 Bourang et al. Nov 2002 A1
20020177890 Lenker Nov 2002 A1
20020183763 Callol et al. Dec 2002 A1
20020188343 Mathis Dec 2002 A1
20020188347 Mathis Dec 2002 A1
20020193873 Brucker et al. Dec 2002 A1
20030028233 Vardi et al. Feb 2003 A1
20030029039 Richter et al. Feb 2003 A1
20030045923 Bashiri Mar 2003 A1
20030093143 Zhao et al. May 2003 A1
20030097169 Brucker et al. May 2003 A1
20030105922 Tomita Jun 2003 A1
20030114912 Sequin et al. Jun 2003 A1
20030114919 Mcquiston et al. Jun 2003 A1
20030114922 Iwasaka et al. Jun 2003 A1
20030125791 Sequin et al. Jul 2003 A1
20030125800 Shulze et al. Jul 2003 A1
20030125802 Callol et al. Jul 2003 A1
20030135259 Simso Jul 2003 A1
20030135266 Chew et al. Jul 2003 A1
20030139796 Sequin et al. Jul 2003 A1
20030139797 Johnson et al. Jul 2003 A1
20030139798 Brown et al. Jul 2003 A1
20030163085 Tanner et al. Aug 2003 A1
20030176909 Kusleika Sep 2003 A1
20030191516 Weldon et al. Oct 2003 A1
20030192164 Austin Oct 2003 A1
20030195609 Berenstein et al. Oct 2003 A1
20030199821 Gerdts Oct 2003 A1
20030204238 Tedeschi Oct 2003 A1
20030212447 Euteneuer et al. Nov 2003 A1
20030225446 Hartley Dec 2003 A1
20040015231 Suhr Jan 2004 A1
20040024450 Shulze et al. Feb 2004 A1
20040030380 Shulze et al. Feb 2004 A1
20040044395 Nelson Mar 2004 A1
20040044398 Nicholas Mar 2004 A1
20040085845 Ooishi May 2004 A1
20040087965 Levine et al. May 2004 A1
20040093061 Acosta et al. May 2004 A1
20040093067 Israel May 2004 A1
20040093077 White et al. May 2004 A1
20040098081 Landreville et al. May 2004 A1
20040106979 Goicoechea et al. Jun 2004 A1
20040111145 Serino et al. Jun 2004 A1
20040117008 Wnendt et al. Jun 2004 A1
20040176832 Hartley et al. Sep 2004 A1
20040186551 Kao et al. Sep 2004 A1
20040193245 Deem et al. Sep 2004 A1
20040215165 Coyle et al. Oct 2004 A1
20040215312 Andreas Oct 2004 A1
20040243217 Andersen et al. Dec 2004 A1
20040249434 Andreas et al. Dec 2004 A1
20040249435 Andreas et al. Dec 2004 A1
20050010276 Acosta et al. Jan 2005 A1
20050038505 Shulze et al. Feb 2005 A1
20050049673 Andreas et al. Mar 2005 A1
20050049680 Fischell et al. Mar 2005 A1
20050080474 Andreas et al. Apr 2005 A1
20050080475 Andreas et al. Apr 2005 A1
20050085845 Hilaire et al. Apr 2005 A1
20050090846 Pedersen et al. Apr 2005 A1
20050101624 Betts et al. May 2005 A1
20050125051 Eidenschink et al. Jun 2005 A1
20050131008 Betts et al. Jun 2005 A1
20050133164 Fischer et al. Jun 2005 A1
20050143827 Globerman et al. Jun 2005 A1
20050149159 Andreas et al. Jul 2005 A1
20050165378 Heinrich et al. Jul 2005 A1
20050182473 Eidenschink et al. Aug 2005 A1
20050183259 Eidenschink et al. Aug 2005 A1
20050197688 Theron et al. Sep 2005 A1
20050209674 Kutscher et al. Sep 2005 A1
20050222671 Schaeffer et al. Oct 2005 A1
20050228477 Grainger et al. Oct 2005 A1
20050245637 Hossainy et al. Nov 2005 A1
20050288763 Andreas et al. Dec 2005 A1
20050288764 Snow et al. Dec 2005 A1
20050288766 Plain et al. Dec 2005 A1
20060025843 Gurm Feb 2006 A1
20060069424 Acosta et al. Mar 2006 A1
20060100694 Globerman May 2006 A1
20060116748 Kaplan et al. Jun 2006 A1
20060123874 Motsenbocker Jun 2006 A1
20060155356 Israel Jul 2006 A1
20060155362 Israel Jul 2006 A1
20060200223 Andreas et al. Sep 2006 A1
20060206190 Chermoni Sep 2006 A1
20060229700 Acosta et al. Oct 2006 A1
20060229706 Shulze et al. Oct 2006 A1
20060271090 Shaked et al. Nov 2006 A1
20060271150 Andreas et al. Nov 2006 A1
20060271151 Mcgarry et al. Nov 2006 A1
20060282147 Andreas Dec 2006 A1
20060282149 Kao Dec 2006 A1
20060282150 Olson et al. Dec 2006 A1
20060287726 Segal et al. Dec 2006 A1
20070027521 Andreas et al. Feb 2007 A1
20070027524 Johnson et al. Feb 2007 A1
20070055351 Eidenschink et al. Mar 2007 A1
20070061003 Shmulewitz et al. Mar 2007 A1
20070067012 George et al. Mar 2007 A1
20070088368 Acosta et al. Apr 2007 A1
20070088420 Andreas et al. Apr 2007 A1
20070088422 Chew et al. Apr 2007 A1
20070100423 Acosta et al. May 2007 A1
20070100424 Chew et al. May 2007 A1
20070106365 Andreas et al. May 2007 A1
20070118202 Chermoni May 2007 A1
20070118203 Chermoni May 2007 A1
20070118204 Chermoni May 2007 A1
20070123970 Lenz May 2007 A1
20070129733 Will et al. Jun 2007 A1
20070156225 George et al. Jul 2007 A1
20070156226 Chew et al. Jul 2007 A1
20070179587 Acosta et al. Aug 2007 A1
20070203571 Kaplan et al. Aug 2007 A1
20070219611 Krever et al. Sep 2007 A1
20070219612 Andreas et al. Sep 2007 A1
20070219613 Kao et al. Sep 2007 A1
20070219625 Venturelli et al. Sep 2007 A1
20070260217 Von et al. Nov 2007 A1
20070264305 Von et al. Nov 2007 A1
20070265637 Andreas et al. Nov 2007 A1
20070270936 Andreas et al. Nov 2007 A1
20070276460 Davis et al. Nov 2007 A1
20070276461 Andreas et al. Nov 2007 A1
20070281117 Kaplan et al. Dec 2007 A1
20070282419 Hilaire et al. Dec 2007 A1
20070292518 Ludwig Dec 2007 A1
20080009932 Ta et al. Jan 2008 A1
20080009933 Ta et al. Jan 2008 A1
20080051869 Yribarren Feb 2008 A1
20080071345 Hammersmark et al. Mar 2008 A1
20080077229 Andreas et al. Mar 2008 A1
20080091257 Andreas et al. Apr 2008 A1
20080097299 Andreas et al. Apr 2008 A1
20080097574 Andreas et al. Apr 2008 A1
20080132989 Snow et al. Jun 2008 A1
20080147162 Andreas et al. Jun 2008 A1
20080171975 Jennings et al. Jul 2008 A1
20080019951 Ruane et al. Aug 2008 A1
20080208309 Saeed Aug 2008 A1
20080208311 Kao et al. Aug 2008 A1
20080208318 Kao et al. Aug 2008 A1
20080221655 Miller Sep 2008 A1
20080234795 Snow et al. Sep 2008 A1
20080234798 Chew et al. Sep 2008 A1
20080234799 Acosta et al. Sep 2008 A1
20080269865 Snow et al. Oct 2008 A1
20090076584 Mao et al. Mar 2009 A1
20090105686 Snow et al. Apr 2009 A1
20090132019 Duffy et al. May 2009 A1
20090143854 Adams et al. Jun 2009 A1
20090171430 Baim et al. Jul 2009 A1
20090182270 Nanavati Jul 2009 A1
20090182409 Feld et al. Jul 2009 A1
20090228088 Lowe et al. Sep 2009 A1
20090240321 Davidson et al. Sep 2009 A1
20090254167 Ricci et al. Oct 2009 A1
20090259285 Duane et al. Oct 2009 A1
20090287289 Sagedahl et al. Nov 2009 A1
20090299454 Jennings et al. Dec 2009 A1
20090319030 Yadin et al. Dec 2009 A1
20090326641 Davis et al. Dec 2009 A1
20100004737 Eidenschink Jan 2010 A1
20100030183 Toner et al. Feb 2010 A1
20100036477 Bronson et al. Feb 2010 A1
20100042199 Burton Feb 2010 A1
20100049298 Hamer et al. Feb 2010 A1
20100057020 Uretsky Mar 2010 A1
20100063571 Roach et al. Mar 2010 A1
20100106238 Hilaire et al. Apr 2010 A1
20100222861 Dibie Sep 2010 A1
20110029061 Ahn et al. Feb 2011 A1
20110282427 Bourang et al. Nov 2011 A1
20110307044 Bourang et al. Dec 2011 A1
20110307045 Bourang et al. Dec 2011 A1
20110307046 Bourang et al. Dec 2011 A1
20110307047 Bourang et al. Dec 2011 A1
20110307052 Bourang et al. Dec 2011 A1
20130268047 Bourang Oct 2013 A1
20140100647 Bourang Apr 2014 A1
20150032196 Bourang et al. Jan 2015 A1
20150073521 Bourang et al. Mar 2015 A1
20150073527 Bourang et al. Mar 2015 A1
20150081001 Bourang et al. Mar 2015 A1
20150081002 Bourang et al. Mar 2015 A1
20150216690 Bourang et al. Aug 2015 A1
20160100966 Bourang Apr 2016 A1
20160256303 Bourang Sep 2016 A1
20170319366 Bourang et al. Nov 2017 A1
Foreign Referenced Citations (104)
Number Date Country
2826760 Aug 2012 CA
1441654 Sep 2003 CN
1788977 Jun 2006 CN
1867374 Nov 2006 CN
101035488 Sep 2007 CN
102215780 Oct 2011 CN
103037813 Apr 2013 CN
103037815 Apr 2013 CN
103037816 Apr 2013 CN
103037817 Apr 2013 CN
103068345 Apr 2013 CN
0203945 Dec 1986 EP
0274129 Jul 1988 EP
0282143 Sep 1988 EP
0505686 Sep 1992 EP
0533960 Mar 1993 EP
0596145 May 1994 EP
0714640 Jun 1996 EP
0897700 Feb 1999 EP
0947180 Oct 1999 EP
1074227 Feb 2001 EP
1258230 Nov 2002 EP
1266638 Dec 2002 EP
1277449 Jan 2003 EP
1523959 Apr 2005 EP
1523960 Apr 2005 EP
1788977 May 2007 EP
1905398 Apr 2008 EP
2036519 Mar 2009 EP
2344068 Jul 2011 EP
2549949 Jan 2013 EP
2549950 Jan 2013 EP
2549951 Jan 2013 EP
2549952 Jan 2013 EP
2549958 Jan 2013 EP
2672925 Dec 2013 EP
2672932 Dec 2013 EP
2672925 Dec 2015 EP
2549951 May 2017 EP
2733689 Nov 1996 FR
1043313 Feb 1998 JP
2003532437 Nov 2003 JP
2004052887 Feb 2004 JP
2004528877 Sep 2004 JP
2007508082 Apr 2007 JP
2010503465 Feb 2010 JP
2012503534 Feb 2012 JP
2013523215 Jun 2013 JP
WO-9013332 Nov 1990 WO
WO-9112779 Sep 1991 WO
WO-9626689 Sep 1996 WO
WO-9633677 Oct 1996 WO
WO-9745073 Dec 1997 WO
WO-9746174 Dec 1997 WO
WO-9748351 Dec 1997 WO
WO-9820810 May 1998 WO
WO-9837833 Sep 1998 WO
WO-9858600 Dec 1998 WO
WO-9901087 Jan 1999 WO
WO-0012832 Mar 2000 WO
WO-0015151 Mar 2000 WO
WO-0025841 May 2000 WO
WO-0032136 Jun 2000 WO
WO-0041649 Jul 2000 WO
WO-0050116 Aug 2000 WO
WO-0062708 Oct 2000 WO
WO-0072780 Dec 2000 WO
WO-0074595 Dec 2000 WO
WO-0170297 Sep 2001 WO
WO-0191918 Dec 2001 WO
WO-02060344 Aug 2002 WO
WO-02085253 Oct 2002 WO
WO-03022178 Mar 2003 WO
WO-03047651 Jun 2003 WO
WO-03051425 Jun 2003 WO
WO-03055414 Jul 2003 WO
WO-03105922 Dec 2003 WO
WO-2004017865 Mar 2004 WO
WO-2004043299 May 2004 WO
WO-2004043301 May 2004 WO
WO-2004043510 May 2004 WO
WO-2004052237 Jun 2004 WO
WO-2005013853 Feb 2005 WO
WO-2005039681 May 2005 WO
WO-2006036939 Apr 2006 WO
WO-2006047520 May 2006 WO
WO-2007035805 Mar 2007 WO
WO-2007053187 May 2007 WO
WO-2007146411 Dec 2007 WO
WO-2008005111 Jan 2008 WO
WO-2008033621 Mar 2008 WO
WO-2008130503 Oct 2008 WO
WO-2009148594 Dec 2009 WO
WO-2009148997 Dec 2009 WO
WO-2010022516 Mar 2010 WO
WO-2010036982 Apr 2010 WO
WO-2011119879 Sep 2011 WO
WO-2011119880 Sep 2011 WO
WO-2011119882 Sep 2011 WO
WO-2011119883 Sep 2011 WO
WO-2011119884 Sep 2011 WO
WO-2012109365 Aug 2012 WO
WO-2012109382 Aug 2012 WO
WO-201210938243 Jan 2013 WO
Non-Patent Literature Citations (131)
Entry
U.S. Appl. No. 13/796,466 U.S. Pat. No. 9,254,210, filed Mar. 12, 2013, Multi-Stent and Multi-Balloon Apparatus for Treating Bifurcations and Methods of Use.
U.S. Appl. No. 14/971,615, filed Dec. 16, 2015, Multi-Stent and Multi-Balloon Apparatus for Treating Bifurcations and Methods of Use.
“U.S. Appl. No. 13/071,149, Final Office Action dated Nov. 5, 2013”, 20 pgs.
“U.S. Appl. No. 13/071,149, Non Final Office Action dated Apr. 11, 2013”, 16 pgs.
“U.S. Appl. No. 13/071,149, Notice of Allowance dated Mar. 26, 2014”, 11 pgs.
“U.S. Appl. No. 13/071,162, Non Final Office Action dated Aug. 30, 2013”, 17 pgs.
“U.S. Appl. No. 13/071,162, Notice of Allowance dated Mar. 31, 2014”, 12 pgs.
“U.S. Appl. No. 13/071,183, Final Office Action dated Nov. 5, 2013”, 35 pgs.
“U.S. Appl. No. 13/071,183, Non Final Office Action dated Mar. 29, 2013”, 23 pgs.
“U.S. Appl. No. 13/071,183, Notice of Allowance dated Mar. 20, 2014”, 13 pgs.
“U.S. Appl. No. 13/071,198, Final Office Action dated Nov. 6, 2013”, 20 pgs.
“U.S. Appl. No. 13/071,198, Non Final Office Action dated Apr. 11, 2013”, 17 pgs.
“U.S. Appl. No. 13/071,198, Notice of Allowance dated Mar. 24, 2014”, 11 pgs.
“U.S. Appl. No. 13/071,239, Final Office Action dated Nov. 26, 2013”, 18 pgs.
“U.S. Appl. No. 13/071,239, Non Final Office Action dated Mar. 14, 2013”, 17 pgs.
“U.S. Appl. No. 13/071,239, Notice of Allowance dated Mar. 4, 2014”, 10 pgs.
“U.S. Appl. No. 13/071,251, Non Final Office Action dated Sep. 10, 2013”, 15 pgs.
“U.S. Appl. No. 13/071,251, Notice of Allowance dated May 28, 2014”, 15 pgs.
“U.S. Appl. No. 13/071,251, Notice of Allowance dated Aug. 13, 2014”, 12 pgs.
“U.S. Appl. No. 13/796,424, Notice of Allowance dated Feb. 16, 2016”, 13 pgs.
“U.S. Appl. No. 13/796,466, Examiner Interview Summary dated Jun. 25, 2015”, 3 pgs.
“U.S. Appl. No. 13/796,466, Non Final Office Action dated Apr. 3, 2015”, 19 pgs.
“U.S. Appl. No. 13/796,466, Notice of Allowance dated Oct. 7, 2015”, 16 pgs.
“U.S. Appl. No. 13/796,466, Notice of Allowance dated Nov. 18, 2015”, 2 pgs.
“U.S. Appl. No. 13/796,466, Response filed Jul. 2, 2015 to Non Final Office Action dated Apr. 3, 2015”, 11 pgs.
“U.S. Appl. No. 14/294,631, Final Office Action dated Mar. 24, 2017”, 15 pgs.
“U.S. Appl. No. 14/294,631, Non Final Office Action dated Sep. 22, 2017”, 16 pgs.
“U.S. Appl. No. 14/294,631, Non Final Office Action dated Oct. 7, 2016”, 15 pgs.
“U.S. Appl. No. 14/313,742, Final Office Action dated Aug. 12, 2016”, 19 pgs.
“U.S. Appl. No. 14/313,742, Non Final Office Action dated Jan. 29, 2016”, 17 pgs.
“U.S. Appl. No. 14/313,742, Non Final Office Action dated Mar. 24, 2017”, 20 pgs.
“U.S. Appl. No. 14/313,742, Notice of Allowance dated Oct. 20, 2017”, 8 pgs.
“U.S. Appl. No. 14/314,361, Non Final Office Action dated Oct. 6, 2016”, 33 pgs.
“U.S. Appl. No. 14/314,361, Notice of Allowance dated Apr. 12, 2017”, 11 pgs.
“U.S. Appl. No. 14/317,387, Non Final Office Action dated Oct. 6, 2016”, 15 pgs.
“U.S. Appl. No. 14/317,387, Notice of Allowance dated Apr. 17, 2017”, 10 pgs.
“U.S. Appl. No. 14/321,506, Non Final Office Action dated Oct. 6, 2016”, 15 pgs.
“U.S. Appl. No. 14/321,506, Notice of Allowance dated Apr. 4, 2017”, 10 pgs.
“U.S. Appl. No. 14/621,231, Final Office Action dated Oct. 20, 2017”, 19 pgs.
“U.S. Appl. No. 14/621,231, Non Final Office Action dated Jun. 15, 2017”, 17 pgs.
“U.S. Appl. No. 14/971,615, Non Final Office Action dated Oct. 18, 2018”, 41 pgs.
“U.S. Appl. No. 14/971,615, Notice of Allowance dated Jun. 12, 2019”, 15 pgs.
“U.S. Appl. No. 14/971,615, Preliminary Amendment filed Dec. 16, 2015”, 9 pgs.
“U.S. Appl. No. 14/971,615, Response filed Mar. 15, 2019 to Non Final Office Action dated Oct. 18, 2018”, 12 pgs.
“U.S. Appl. No. 14/971,615, Response filed Jul. 18, 2018 to Restriction Requirement dated Jan. 18, 2018”, 1 pg.
“U.S. Appl. No. 14/971,615, Restriction Requirement dated Jan. 18, 2018”, 8 pgs.
“U.S. Appl. No. 15/157,321, Non Final Office Action dated Aug. 11, 2017”, 10 pgs.
“Australian Application Serial No. 2011232357, First Examination Report dated Dec. 3, 2014”, 2 pgs.
“Australian Application Serial No. 2011232358, First Examination Report dated Dec. 5, 2014”, 2 pgs.
“Australian Application Serial No. 2011232360, First Examination Report dated Dec. 9, 2014”, 2 pgs.
“Australian Application Serial No. 2011232361, First Examination Report dated Dec. 12, 2014”, 3 pgs.
“Australian Application Serial No. 2011232362, First Examination Report dated Jan. 11, 2015”, 2 pgs.
“Canadian Application Serial No. 2,826,760, Voluntary Amendment filed Aug. 7, 2013”, 8 pgs.
“Chinese Application Serial No. 200980143592.X, Final Office Action dated Jun. 4, 2013”, 10 pgs.
“Chinese Application Serial No. 200980143592.X, Office Action dated Apr. 21, 2014”, w/ English Translation, 18 pgs.
“Chinese Application Serial No. 200980143592.X, Office Action dated Jun. 4, 2013”, 10 pgs.
“Chinese Application Serial No. 2009801473592.X, Office Action dated Apr. 21, 2014”, 26 pgs.
“Chinese Application Serial No. 2009801473592.X, Office Action dated Nov. 24, 2014”, 16 pgs.
“Chinese Application Serial No. 201180025662.9, Office Action dated Aug. 21, 2014”, 25 pgs.
“Chinese Application Serial No. 201180025670.3, Office Action dated Aug. 20, 2014”, 24 pgs.
“Chinese Application Serial No. 201180025716.1, Office Action dated Aug. 22, 2014”, 28 pgs.
“Chinese Application Serial No. 201180025742.4, Office Action dated Oct. 29, 2014”, 12 pgs.
“Chinese Application Serial No. 201180025746.2, Office Action dated Sep. 28, 2014”, 21 pgs.
“Drug Delivery Stent With Holes Located On Neutral Axis”, No. 429007; Research Disclosure, Kenneth Mason Publications, Hampshire, CB vol. 2266, (Jan. 2000), 13 pgs.
“European Application Serial No. 05727731.1, Supplementary European Search Report dated Apr. 8, 2008”, 3 pgs.
“European Application Serial No. 05744136.2, Supplementary European Search Report dated Apr. 9, 2008”, 3 pgs.
“European Application Serial No. 09816963.4, Extended European Search Report dated Aug. 21, 2015”, 5 pgs.
“European Application Serial No. 11760253.2, Extended European Search Report dated Feb. 22, 2017”, 7 pgs.
“European Application Serial No. 11760254.0, Extended European Search Report dated Apr. 12, 2017”, 6 pgs.
“European Application Serial No. 11760256.5, Extended European Search Report dated Aug. 12, 2016”, 8 pgs.
“European Application Serial No. 11760257.3, Extended European Search Report dated Sep. 29, 2015”, 7 pgs.
“European Application Serial No. 11760258.1, Extended European Search Report dated Dec. 5, 2016”, 8 pgs.
“European Application Serial No. 12744749.8, Extended European Search Report dated Apr. 7, 2016”, 10 pgs.
“European Application Serial No. 12744813.2, Extended European Search Report dated Nov. 25, 2015”, 9 pgs.
“European Application Serial No. 12744813.2, Intention to Grant dated Mar. 22, 2017”, 48 pgs.
“European Application Serial No. 12744813.2, Intention to Grant dated Aug. 18, 2016”, 51 pgs.
“European Application Serial No. 12744813.2, Response filed Jun. 13, 2016 to Extended European Search Report dated Nov. 25, 2015”, 28 pgs.
“Functional Sites on Non-polymeric Materials: Gas Plasma Treatment and Surface Analysis”, Evans Analytical Group, [Online] Retrieved from the internet: <http://www.eaglabs.com>, (2003), 2 pgs.
“International Application Serial No. PCT/US2009/058505, International Preliminary Report on Patentability dated Oct. 28, 2010”, 11 pgs.
“International Application Serial No. PCT/US2009/058505, International Search Report dated Nov. 25, 2009”, 2 pgs.
“International Application Serial No. PCT/US2009/058505, Written Opinion dated Nov. 25, 2009”, 9 pgs.
“International Application Serial No. PCT/US2011/029858, International Search Report dated May 25, 2011”, 2 pgs.
“International Application Serial No. PCT/US2011/029858, Written Opinion dated May 25, 2011”, 7 pgs.
“International Application Serial No. PCT/US2011/029859, International Preliminary Report on Patentability dated Oct. 4, 2012”, 8 pgs.
“International Application Serial No. PCT/US2011/029859, International Search Report dated May 23, 2011”, 2 pgs.
“International Application Serial No. PCT/US2011/029859, Written Opinion dated May 23, 2011”, 6 pgs.
“International Application Serial No. PCT/US2011/029861, International Preliminary Report on Patentability dated Oct. 4, 2012”, 9 pgs.
“International Application Serial No. PCT/US2011/029861, International Search Report dated May 20, 2011”, 2 pgs.
“International Application Serial No. PCT/US2011/029861, Written Opinion dated May 20, 2011”, 7 pgs.
“International Application Serial No. PCT/US2011/029862, International Preliminary Report on Patentability dated Oct. 4, 2012”, 11 pgs.
“International Application Serial No. PCT/US2011/029862, International Search Report dated May 25, 2011”, 2 pgs.
“International Application Serial No. PCT/US2011/029862, Written Opinion dated May 25, 2011”, 9 pgs.
“International Application Serial No. PCT/US2011/029863, International Preliminary Report on Patentability dated Oct. 4, 2012”, 13 pgs.
“International Application Serial No. PCT/US2011/029863, International Search Report dated May 27, 2011”, 2 pgs.
“International Application Serial No. PCT/US2011/029863, Written Opinion dated May 27, 2011”, 11 pgs.
“International Application Serial No. PCT/US2012/024347, International Preliminary Report on Patentability dated Aug. 22, 2013”, 9 pgs.
“International Application Serial No. PCT/US2012/024347, International Search Report dated Jun. 29, 2012”, 2 pgs.
“International Application Serial No. PCT/US2012/024347, Written Opinion dated Jun. 29, 2012”, 7 pgs.
“International Application Serial No. PCT/US2012/024366, International Preliminary Report on Patentability dated Aug. 22, 2013”, 20 pgs.
“International Application Serial No. PCT/US2012/024366, International Search Report dated Sep. 7, 2012”, 3 pgs.
“International Application Serial No. PCT/US2012/024366, Invitation to Pay Additional Fees and Partial Search Report dated Jun. 1, 2012”, 3 pgs.
“International Application Serial No. PCT/US2012/024366, Written Opinion dated Sep. 7, 2012”, 18 pgs.
“Japanese Application Serial No. 2011-529290, Office Action dated Sep. 25, 2013”, 5 pgs.
“Japanese Application Serial No. 2013-501497, Office Action dated Nov. 5, 2014”, 7 pgs.
“Stent”, Unabridged (v1.01 ), [Online]. Retrieved from the Internet: <http://dictionary.reference.com/search?q=stent>, (Sep. 22, 2006), 1 pg.
Aaron, Kaplan V, “U.S. Appl. No. 09/225,364, filed Jan. 4, 1999”, (Jan. 4, 1999).
Bernard, Andreas, “U.S. Appl. No. 60/336,607, filed Dec. 3, 2001”.
Bernard, Andreas, “U.S. Appl. No. 60/336,767, filed Dec. 3, 2001”.
Bernard, Andreas, “U.S. Appl. No. 60/440,839, filed Jan. 17, 2003”.
Bernard, Andreas, “U.S. Appl. No. 60/784,309, filed Mar. 20, 2006”.
Bourang, Henry, et al., “U.S. Appl. No. 14/294,631, filed Jun. 3, 2014”, 151 pgs.
Bourang, Henry, et al., “U.S. Appl. No. 14/313,742, filed Jun. 24, 2014”, 142 pgs.
Bourang, Henry, et al., “U.S. Appl. No. 14/314,361, filed Jun. 25, 2014”, 132 pgs.
Bourang, Henry, et al., “U.S. Appl. No. 14/317,387, filed Jun. 27, 2014”, 39 pgs.
Bourang, Henry, et al., “U.S. Appl. No. 14/321,506, filed Jul. 1, 2014”, 131 pgs.
Bourang, Henry, et al., “U.S. Appl. No. 14/621,231, filed Feb. 12, 2015”, 138 pgs.
Bourang, Henry, et al., “U.S. Appl. No. 15/831,110, filed Dec. 1, 2017”, 130 pgs.
Colombo, “The Invatec Bifurcation Stent Solution”, Colombo Bifurcation Stents: Novel Solutions, TCT Washington, (Sep. 15-19, 2003), 24 pgs.
Cooley, Patrick, et al., “Applications of Ink-Jet Printing Technology to BioMEMs and Microfluidic Systems”, Proceedings, SPIE Conference on Microfluidics and BioMEMs, (Oct. 2001), 12 pgs.
Dichek, et al., “Seeding of intravascular stents with genetically engineered endothelial cells”, Circulation. vol. 80, No. 5, (1989), 7 pgs.
Enrique, Klein J, “U.S. Appl. No. 09/097,855, filed Jun. 15, 1998”.
Jeffry, Grainger, “U.S. Appl. No. 60/561,041, filed Apr. 9, 2004”.
Joung, Yoon Ki, et al., “Estrogen Release from Metallic Stent Surface for the Prevention of Restenosis”, Journal of Controlled Release vol. 92, (2003), 83-91.
Lefevre, Thierry, et al., “Approach to Coronary Bifurcation Stenting in 2003”, Euro PCR, (May 2003), 127-154.
Pablo, Acosta, et al., “U.S. Appl. No. 10/874,859, filed Jun. 22, 2004”.
Patrick, Ruane, “U.S. Appl. No. 60/890,703, filed Feb. 20, 2007”.
Patrick, Ruane, “U.S. Appl. No. 61/012,317, filed Dec. 7, 2007”.
Stephen, Kaplan, “U.S. Appl. No. 60/810,522, filed Jun. 2, 2006”.
Stimpson, Donald I, et al., “Parallel Production of Oligonucleotide Arrays Using Membranes and Reagent Jet Printing”, Bio Techniques; vol. 25, (Nov. 1998), 886-890.
Sunmi, Chew, “U.S. Appl. No. 60/336,967, filed Dec. 3, 2001”.
Sunmi, Chew, “U.S. Appl. No. 60/364,389, filed Mar. 13, 2002”.
Related Publications (1)
Number Date Country
20190350733 A1 Nov 2019 US
Provisional Applications (1)
Number Date Country
61440742 Feb 2011 US
Continuations (3)
Number Date Country
Parent 14971615 Dec 2015 US
Child 16527602 US
Parent 13796466 Mar 2013 US
Child 14971615 US
Parent PCT/US2012/024366 Feb 2012 US
Child 13796466 US